[go: up one dir, main page]

CN100361705C - A traditional Chinese medicine composition for treating chronic atrophic gastritis - Google Patents

A traditional Chinese medicine composition for treating chronic atrophic gastritis Download PDF

Info

Publication number
CN100361705C
CN100361705C CNB200510107415XA CN200510107415A CN100361705C CN 100361705 C CN100361705 C CN 100361705C CN B200510107415X A CNB200510107415X A CN B200510107415XA CN 200510107415 A CN200510107415 A CN 200510107415A CN 100361705 C CN100361705 C CN 100361705C
Authority
CN
China
Prior art keywords
chinese medicine
medicine composition
traditional chinese
atrophic gastritis
chronic atrophic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB200510107415XA
Other languages
Chinese (zh)
Other versions
CN1745844A (en
Inventor
金东明
刘志强
越皓
王彩霞
刘淑莹
宋凤瑞
皮子凤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changchun Institute of Applied Chemistry of CAS
Original Assignee
Changchun Institute of Applied Chemistry of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changchun Institute of Applied Chemistry of CAS filed Critical Changchun Institute of Applied Chemistry of CAS
Priority to CNB200510107415XA priority Critical patent/CN100361705C/en
Publication of CN1745844A publication Critical patent/CN1745844A/en
Application granted granted Critical
Publication of CN100361705C publication Critical patent/CN100361705C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

本发明涉及一种治疗慢性萎缩性胃炎的中药组合物。该中药组合物的成分及重量百分比为:法半夏3.5%-4%,黄连18%-19%,干姜18%-19%,人参9%-9.5%,黄芩18%-19%,厚朴9%-9.5%,乳香3.5%-4%,炙甘草18%-19%。该药可用于治疗慢性萎缩性胃炎寒热错杂症。本发明涉及的中药组合物临床治愈率占10%;显效率占33%;有效率占43%;总有效率87%。The invention relates to a traditional Chinese medicine composition for treating chronic atrophic gastritis. The composition and weight percentage of the traditional Chinese medicine composition are: 3.5%-4% of Pinellia chinensis, 18%-19% of Coptis chinensis, 18%-19% of dried ginger, 9%-9.5% of ginseng, 18%-19% of Scutellaria baicalensis, thick Park 9%-9.5%, frankincense 3.5%-4%, roasted licorice 18%-19%. The medicine can be used for the treatment of chronic atrophic gastritis with mixed cold and heat. The clinical cure rate of the traditional Chinese medicine composition involved in the present invention accounts for 10%; the effective rate accounts for 33%; the effective rate accounts for 43%; and the total effective rate accounts for 87%.

Description

一种治疗慢性萎缩性胃炎的中药组合物 A traditional Chinese medicine composition for treating chronic atrophic gastritis

技术领域technical field

本发明属于中药领域,涉及一种治疗慢性萎缩性胃炎的中药组合物。The invention belongs to the field of traditional Chinese medicines and relates to a traditional Chinese medicine composition for treating chronic atrophic gastritis.

背景技术Background technique

慢性萎缩性胃炎是以胃粘膜腺体萎缩为特征的一种常见消化道疾病,WHO将其列为胃癌的癌前状态,目前还没有根治慢性萎缩性胃炎的特效药。常用中药方剂如四逆散(出自《伤寒论》,载于《方剂学》58页)、三仁汤(出自《温病条辨》,载于《方剂学讲义》190页)、香砂六君子汤(出自《时方歌括》,载于《温病学》231页)、沙参麦冬汤(出自《温病条辨》,载于《方剂学》231页)等施治原理不同,但都不能全面的治疗慢性萎缩性胃炎。Chronic atrophic gastritis is a common digestive tract disease characterized by atrophy of gastric mucosal glands. WHO lists it as a precancerous state of gastric cancer. Currently, there is no specific drug for chronic atrophic gastritis. Commonly used traditional Chinese medicine prescriptions such as Sini Powder (from "Treatise on Febrile Diseases", contained in "Prescription Science" page 58), Sanren Decoction (from "Warm Disease Tiaobian", contained in "Prescription Science Lecture Notes" page 190), Xiangsha Liu Junzi Decoction (from "Shi Fang Ge Kuo", contained in "Fresh Diseases", page 231), Shashen Maidong Decoction (from "Febrile Diseases", contained in "Prescriptions", page 231) and other treatment principles are different , but none of them can comprehensively treat chronic atrophic gastritis.

发明内容Contents of the invention

本发明的目的是提供一种治疗慢性萎缩性胃炎的中药组合物。本发明能有效遏制胃粘膜萎缩,阻碍其向癌发展,具有很好的疗效。The object of the invention is to provide a traditional Chinese medicine composition for treating chronic atrophic gastritis. The invention can effectively restrain the atrophy of the gastric mucosa, hinder its development to cancer, and has good curative effect.

本发明的一种治疗慢性萎缩性胃炎的中药组合物,按照君、臣、、使进行组方:法半夏为君药;黄连、干姜、人参为臣药;黄芩、厚朴、乳香为佐药;炙甘草为使药;并且中药组合物的组成成分及重量百分比为:法半夏3.5%-4%,黄连18%-19%,干姜18%-19%,人参9%-9.5%,黄芩18%-19%,厚朴9%-9.5%,乳香3.5%-4%,炙甘草18%-19%。A traditional Chinese medicine composition for treating chronic atrophic gastritis of the present invention is formulated according to monarch, minister, and envoy: Pinellia is the monarch drug; Coptidis Rhizome, dried ginger, and ginseng are minister drugs; Scutellaria baicalensis, Magnolia officinalis, and frankincense are adjuvant drugs Radix Glycyrrhiza is used as medicine; and the composition and weight percentage of the traditional Chinese medicine composition are: Pinellia chinensis 3.5%-4%, Coptidis 18%-19%, dried ginger 18%-19%, ginseng 9%-9.5%, Scutellaria baicalensis 18%-19%, Magnolia officinalis 9%-9.5%, frankincense 3.5%-4%, roasted licorice 18%-19%.

本发明的一种治疗慢性萎缩性胃炎的中药组合物系根据中医药学理论,按照君、臣、佐、使进行组方:法半夏为君药;黄连、干姜、人参为臣药;黄芩、厚朴、乳香为佐药;炙甘草为使药;A traditional Chinese medicine composition for treating chronic atrophic gastritis of the present invention is based on the theory of traditional Chinese medicine, according to the prescription of monarch, minister, adjuvant and envoy: Pinellia is the monarch drug; Coptis chinensis, dried ginger and ginseng are minister drugs; Pu and frankincense are adjuvant medicines; roasted licorice is an envoy;

下面,根据中医药学理论,对本发明的一种治疗慢性萎缩性胃炎的中药组合物的配伍组分进一步予以说明:Below, according to the theory of traditional Chinese medicine, the compatible components of a kind of Chinese medicine composition for treating chronic atrophic gastritis of the present invention are further described:

半夏为君药。发挥其健脾和胃,散结消痞,降逆除胀止痛作用,主治脾胃虚弱,寒热错杂脾证;黄连,协助君药祛湿调中,发挥其清热燥湿,调胃厚肠,坚阴止痢作用;干姜,协助君药,发挥其温补脾胃,散寒降逆止痛作用;人参,协助君药,发挥其补中缓急作用;黄芩,协助黄连清热,发挥其清热燥湿,坚阴止利作用;厚朴,协助半夏、干姜温中降逆,发挥其行气燥湿,除胀消积作用;乳香,协助半夏、干姜辛散,发挥其行气止痛化瘀作用;炙甘草,一方面,佐助人参补中虚,另一方面,调和诸药,使药性调和,利于养胃。Pinellia is the king medicine. Give play to its invigorating the spleen and harmonizing the stomach, dissipating stagnation and eliminating swelling, lowering the adverse effect of removing swelling and relieving pain, and mainly treating weakness of the spleen and stomach, cold and heat mixed spleen syndrome; Coptis chinensis, assisting the monarch drug in dispelling dampness and regulating the middle, exerting its heat-clearing and damp-drying, regulating the stomach and thickening the intestines, strengthening the Yin and stop dysentery; Dried ginger, assisting the monarch drug, exerts its effect of warming and tonifying the spleen and stomach, dispelling cold and reducing adverse reactions; Magnolia officinalis, assists pinellia and dried ginger to warm the middle and reduce adverse events, exerts its function of promoting qi, drying dampness, eliminating swelling and eliminating accumulation; frankincense, assists pinellia and dried ginger, exerts its function of promoting qi, relieving pain and removing blood stasis; Roasted licorice, on the one hand, assists ginseng to invigorate the deficiency in the middle, on the other hand, reconciles various medicines to harmonize the properties of the medicine, which is beneficial to nourishing the stomach.

本发明的制备方法是,将配比量的2/5的人参与全部配比量的乳香粉碎成细粉,备用。配比量的黄连加水煎煮,滤过,合并滤液,减压浓缩至相对密度1.10-1.15(25℃)的清膏,醇沉(使乙醇浓度达到65%-75%),搅拌均匀,静置24小时,滤过,减压回收乙醇并浓缩至相对密度1.30-1.35(50℃)的稠膏,80℃干燥,粉碎成细粉;配比量的干姜加水浸泡,水蒸汽蒸馏提取挥发油,药渣及蒸馏后水液备用。挥发油用β-环糊精包合,抽滤,沉淀物烘干备用;将上述药渣与配比量的黄芩、厚朴,炙甘草、法半夏及配比量的3/5的人参加水煎煮,滤过,滤液与干姜蒸馏后水液合并,减压浓缩至相对密度1.10-1.15(25℃)的清膏,醇沉(使乙醇浓度达到65%-75%),搅拌均匀,静置24小时,滤过,减压回收乙醇并浓缩至相对密度1.30-1.35(50℃)的稠膏,加入上述细粉,搅拌均匀,80℃干燥,粉碎成细粉,与黄连浸膏粉及包合物混合均匀即得本发明的中药组合物;本发明还可以继续用中药公知的技术方法制成任何固体剂型,包括胶囊剂、片剂、散剂或丸剂。The preparation method of the present invention comprises: pulverizing 2/5 of the proportioning amount of ginseng into a fine powder and putting it aside for later use. Coptidis Rhizoma Coptidis in proportion is decocted with water, filtered, combined filtrates, concentrated under reduced pressure to a clear paste with a relative density of 1.10-1.15 (25°C), alcohol precipitation (to make the ethanol concentration reach 65%-75%), stirred evenly, and statically Set aside for 24 hours, filter, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30-1.35 (50°C), dry at 80°C, and pulverize into fine powder; soak the proportioned amount of dried ginger in water, steam distillation to extract volatile oil , dregs and distilled water for later use. The volatile oil is clathrated with β-cyclodextrin, suction filtered, and the sediment is dried for later use; the above-mentioned medicinal residues are mixed with the proportioned amount of Scutellaria baicalensis, Magnolia officinalis officinalis, Zhigancao, Fa Pinellia, and 3/5 of the proportioned amount. Decoct with water, filter, combine the filtrate with the dried ginger after distillation, concentrate under reduced pressure to a clear paste with a relative density of 1.10-1.15 (25°C), precipitate with alcohol (to make the ethanol concentration reach 65%-75%), and stir evenly , stand still for 24 hours, filter, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30-1.35 (50°C), add the above fine powder, stir evenly, dry at 80°C, crush into fine powder, and mix with Coptis chinensis extract Mix the powder and the clathrate evenly to obtain the traditional Chinese medicine composition of the present invention; the present invention can also continue to use the known techniques of traditional Chinese medicine to make any solid dosage form, including capsules, tablets, powders or pills.

使用本发明的治疗慢性萎缩性胃炎的中药组合物治疗慢性萎缩性胃炎60例,治疗效果如下:Use the Chinese medicine composition for the treatment of chronic atrophic gastritis of the present invention to treat 60 cases of chronic atrophic gastritis, and the therapeutic effect is as follows:

参照卫生部《中药新药治疗慢性萎缩性胃炎临床指导原则》、《现代中医内科诊断治疗学》、《实用中医内科学》、全国高等专科医药院校教材《内科学》等诊断标准治疗慢性萎缩性胃炎60例,中医辩证属寒热错杂证,临床症状以胃部饱胀满闷、胀痛、食欲不振、嗳气、嘈杂泛酸、大便溏薄或干结、乏力、消瘦、食辛辣、凉、腻食物胃胀痛不适加重为主,舌象以舌淡或红、苔薄白、黄或腻为主,脉象以脉沉弦、细、缓为主。60例患者中,临床治愈6例,占10%;显效20例,占33%;有效26例,占43%;无效8例,占13%,总有效率87%。Treat chronic atrophic gastritis with reference to the Ministry of Health's "Clinical Guidelines for the Treatment of Chronic Atrophic Gastritis with New Drugs of Traditional Chinese Medicine", "Diagnosis and Therapeutics of Modern Traditional Chinese Medicine", "Practical Internal Medicine of Traditional Chinese Medicine", and the textbook "Internal Science" of national medical colleges and universities. 60 cases of gastritis, TCM dialectics belong to mixed syndrome of cold and heat, clinical symptoms include stomach fullness, fullness, pain, loss of appetite, belching, noisy pantothenic acid, loose or dry stool, fatigue, weight loss, eating spicy, cold, greasy food stomach Distending pain and discomfort are mainly aggravated. The tongue is mainly pale or red, with thin white, yellow or greasy fur. The pulse is mainly deep and stringy, thin and slow. Among the 60 patients, 6 cases were clinically cured, accounting for 10%; 20 cases were markedly effective, accounting for 33%; 26 cases were effective, accounting for 43%; 8 cases were ineffective, accounting for 13%, and the total effective rate was 87%.

具体实施方式Detailed ways

实施例1:本发明的一种治疗慢性萎缩性胃炎的中药组合物,按照君、臣、佐、使进行组方:法半夏为君药;黄连、干姜、人参为臣药;黄芩、厚朴、乳香为佐药;炙甘草为使药;并且该中药组合物的组成成分及其重量百分比为:法半夏3.7%,黄连18.5%,干姜18.5%,人参9.3%,黄芩18.5%,厚朴9.3%,乳香3.7%,炙甘草18.5%。Embodiment 1: A kind of Chinese medicine composition for the treatment of chronic atrophic gastritis of the present invention, carries out prescription according to monarch, minister, adjuvant, envoy: Fa Pinellia is monarch medicine; , frankincense is an adjuvant drug; Radix Glycyrrhiza is an envoy; and the composition and weight percentages of the Chinese medicine composition are: Pinellia chinensis 3.7%, Coptidis 18.5%, dried ginger 18.5%, ginseng 9.3%, scutellaria baicalensis 18.5%, thick Pu 9.3%, frankincense 3.7%, roasted licorice 18.5%.

实施例2:Example 2:

本发明的一种治疗慢性萎缩性胃炎的中药组合物,按照君、臣、佐、使进行组方:法半夏为君药;黄连、干姜、人参为臣药;黄芩、厚朴、乳香为佐药;炙甘草为使药;并且该中药胶囊组成成分及其重量百分比为:法半夏3.5%,黄连19%,干姜18%,人参9.5%,黄芩18%,厚朴9.5%,乳香4%,炙甘草18%。A traditional Chinese medicine composition for treating chronic atrophic gastritis of the present invention is formulated according to monarch, minister, adjuvant and envoy: Fa Pinellia is the monarch drug; Coptidis Rhizoma, Dried Ginger, and Ginseng are minister drugs; Scutellaria baicalensis, Magnolia officinalis, and frankincense are assistants. Radix Glycyrrhiza is used as medicine; and the composition and weight percentage of the Chinese medicine capsule are: Pinellia chinensis 3.5%, Coptidis 19%, dried ginger 18%, ginseng 9.5%, Scutellaria baicalensis 18%, Magnolia officinalis 9.5%, frankincense 4% %, Zhi Licorice 18%.

实施例3:Example 3:

本发明的一种治疗慢性萎缩性胃炎的中药组合物,按照君、臣、佐、使进行组方:法半夏为君药;黄连、干姜、人参为臣药;黄芩、厚朴、乳香为佐药;炙甘草为使药;并且该中药胶囊组成成分及其重量百分比为:法半夏4%,黄连18%,干姜19%,人参9%,黄芩19%,厚朴9%,乳香3.5%,炙甘草19%。A traditional Chinese medicine composition for treating chronic atrophic gastritis of the present invention is formulated according to monarch, minister, adjuvant and envoy: Fa Pinellia is the monarch drug; Coptidis Rhizoma, Dried Ginger, and Ginseng are minister drugs; Scutellaria baicalensis, Magnolia officinalis, and frankincense are assistants. Radix Glycyrrhiza is used as medicine; and the composition and weight percentage of the Chinese medicine capsule are: Pinellia 4%, Coptidis 18%, Dried Ginger 19%, Ginseng 9%, Scutellaria baicalensis 19%, Magnolia officinalis 9%, Frankincense 3.5% %, Zhi Licorice 19%.

制备方法实施例1:Preparation method embodiment 1:

取人参100g(3.7%)与乳香100g(3.7%)粉碎成细粉,备用。黄连500g(18.5%)加水煎煮,滤过,合并滤液,减压浓缩至相对密度1.10-1.15(25℃)的清膏,醇沉(使乙醇浓度达到65%-75%),搅拌均匀,静置24小时,滤过,减压回收乙醇并浓缩至相对密度1.30-1.35(50℃)的稠膏,80℃干燥,粉碎成细粉。干姜500g(18.5%)加水浸泡,水蒸汽蒸馏提取挥发油,药渣及蒸馏后水液备用。挥发油用β-环糊精包合,抽滤,沉淀物烘干备用。将上述药渣与黄芩500g(18.5%)、人参150g(5.6%)、厚朴250g(9.3%),炙甘草500g(18.5%)、法半夏100g(3.7%)加水煎煮,滤过,滤液与干姜蒸馏后水液合并,减压浓缩至相对密度1.10-1.15(25℃)的清膏,醇沉(使乙醇浓度达到65%-75%),搅拌均匀,静置24小时,滤过,减压回收乙醇并浓缩至相对密度1.30-1.35(50℃)的稠膏,加入上述细粉,搅拌均匀,80℃干燥,粉碎成细粉,与黄连浸膏粉及包合物混合均匀即得本发明的中药组合物。Get ginseng 100g (3.7%) and frankincense 100g (3.7%) and grind into fine powder, set aside. Add 500 g (18.5%) of Coptidis Rhizome to decoct with water, filter, combine the filtrates, concentrate under reduced pressure to a clear paste with a relative density of 1.10-1.15 (25°C), precipitate with alcohol (to make the ethanol concentration reach 65%-75%), stir evenly, Stand still for 24 hours, filter, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30-1.35 (50°C), dry at 80°C, and pulverize into fine powder. Dried ginger 500g (18.5%) is soaked in water, steam distillation extracts volatile oil, medicinal residues and distilled water for later use. The volatile oil was clathrated with β-cyclodextrin, filtered with suction, and the precipitate was dried for later use. Decoct the above medicinal residues with 500g (18.5%) of Scutellaria baicalensis, 150g (5.6%) of ginseng, 250g (9.3%) of Magnolia bark, 500g (18.5%) of roasted licorice, and 100g (3.7%) of Pinellia chinensis, and filter. The filtrate and dried ginger are distilled and the water liquid is combined, concentrated under reduced pressure to a clear paste with a relative density of 1.10-1.15 (25°C), alcohol precipitation (making the ethanol concentration reach 65%-75%), stirring evenly, standing for 24 hours, and filtering After that, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30-1.35 (50°C), add the above-mentioned fine powder, stir evenly, dry at 80°C, crush into fine powder, and mix evenly with Coptis chinensis extract powder and clathrate That is, the Chinese medicine composition of the present invention is obtained.

制备方法施例2:Preparation method embodiment 2:

取人参115g(4%)与乳香115g(4%)粉碎成细粉,备用。黄连545g(19%)加水煎煮,滤过,合并滤液,减压浓缩至相对密度1.10-1.15(25℃)的清膏,醇沉(使乙醇浓度达到65%-75%),搅拌均匀,静置24小时,滤过,减压回收乙醇并浓缩至相对密度1.30-1.35(50℃)的稠膏,80℃干燥,粉碎成细粉。干姜515g(18%)加水浸泡,水蒸汽蒸馏提取挥发油,药渣及蒸馏后水液备用。挥发油用β-环糊精包合,抽滤,沉淀物烘干备用。将上述药渣与黄芩515g(18%)、人参155g(5%)、厚朴270(9.5%),炙甘草515g(18%)、法半夏100g(3.5%)加水煎煮,滤过,滤液与干姜蒸馏后水液合并,减压浓缩至相对密度1.10-1.15(25℃)的清膏,醇沉(使乙醇浓度达到65%-75%),搅拌均匀,静置24小时,滤过,减压回收乙醇并浓缩至相对密度1.30-1.35(50℃)的稠膏,加入上述细粉,搅拌均匀,80℃干燥,粉碎成细粉,与黄连浸膏粉及包合物混合均匀即得本发明的中药组合物。Get ginseng 115g (4%) and frankincense 115g (4%) and grind into fine powder, set aside. Add 545g (19%) of Coptidis Rhizome to decoct with water, filter, combine the filtrates, concentrate under reduced pressure to a clear paste with a relative density of 1.10-1.15 (25°C), precipitate with alcohol (to make the ethanol concentration reach 65%-75%), stir evenly, Stand still for 24 hours, filter, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30-1.35 (50°C), dry at 80°C, and pulverize into fine powder. Dried ginger 515g (18%) is soaked in water, steam distillation extracts volatile oil, medicinal dregs and water liquid after distillation are set aside. The volatile oil was clathrated with β-cyclodextrin, filtered with suction, and the precipitate was dried for later use. Add water to decoct the above-mentioned medicinal residues, 515g (18%) of Scutellaria baicalensis, 155g (5%) of ginseng, 270 bark officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis officinalis Magnolia officinalis officinalis Officinalis Magnolia officinalis Bark 270 (9.5%), Zhi licorice 515g (18%), Pinellia chinensis 100g (3.5%) and decoct in water, filter, The filtrate and dried ginger are distilled and the water liquid is combined, concentrated under reduced pressure to a clear paste with a relative density of 1.10-1.15 (25°C), alcohol precipitation (making the ethanol concentration reach 65%-75%), stirring evenly, standing for 24 hours, and filtering After that, recover ethanol under reduced pressure and concentrate to a thick paste with a relative density of 1.30-1.35 (50°C), add the above-mentioned fine powder, stir evenly, dry at 80°C, crush into fine powder, and mix evenly with Coptis chinensis extract powder and clathrate That is, the Chinese medicine composition of the present invention is obtained.

本发明的治疗实施例1  袁某,男,33岁,长春市人。患胃胀,胃痛,消瘦1年。每与饮食不当而胃痛,彻夜不眠。平素胃饱胀,无食欲,大便干稀不调,易感冒,身体消瘦明显。于市内多家医院诊为慢性萎缩性胃炎。查:舌苔红,苔白腻,脉沉缓。中医诊断为痞证,辨证属寒热错杂,用复方夏连胶囊汤剂治疗1个月,症状明显减轻。原方小量服用近3个月,症状全无,体重增加。5年后随访,未再复发。Treatment example 1 of the present invention Yuan, male, 33 years old, from Changchun City. Suffering from bloating, stomach pain, weight loss for 1 year. Stomach pain every time with improper diet, sleepless all night. I usually have a full stomach, no appetite, dry and loose stools, easy to catch colds, and obvious body weight loss. Examined as chronic atrophic gastritis in many hospitals in the city. Look into: red tongue fur, white and greasy fur, deep and slow pulse. Diagnosed by traditional Chinese medicine as lump syndrome, syndrome differentiation is mixed cold and heat, treated with compound Xialian capsule decoction for 1 month, the symptoms were obviously relieved. The original prescription has been taken in a small amount for nearly 3 months, no symptoms at all, and weight gain. Follow up a case by regular visits to after 5 years, do not relapse again.

本发明的治疗实施例2  郝某,男,45岁,长春市人。疼痛,胃中胀满,嘈杂10余年,加重1年。因其是出租车司机,饮食无规律,饥饱不调引起发病。由市内多家医院诊为慢性萎缩性胃炎,服用中西药物无效。平素食欲不振,胃中饱胀,嘈杂,胃痛,常在行车时用手顶住胃部以缓解疼痛。大便干稀不调,极易疲劳,睡眠后疲劳不能解除,身体极度消瘦,用手揉摸胃部觉舒。查舌淡、苔薄黄干,脉细。中医辩证为胃脘痛,证属寒热错杂,治用复方夏连胶囊汤剂。2周后,症状明显改善,3个月后,症状消失,5年后随访,未再复发,身体健壮。Treatment Example 2 of the present invention Hao, male, 45 years old, from Changchun City. Pain, fullness in the stomach, noisy for more than 10 years, aggravated for 1 year. Because he is a taxi driver, his diet is irregular, and his hunger and fullness are not adjusted to cause the disease. It was diagnosed as chronic atrophic gastritis by many hospitals in the city, and taking Chinese and Western medicines was ineffective. Ordinary loss of appetite, full stomach, noisy, stomach pain, often with hands against the stomach to relieve pain while driving. Dry and loose stools, easy fatigue, fatigue can not be relieved after sleep, the body is extremely thin, and the stomach feels comfortable when rubbed with hands. Look into pale tongue, thin yellow fur, thready pulse. The TCM syndrome is epigastric pain, and the syndrome is cold and heat mixed. Compound Xialian Capsule Decoction is used for treatment. After 2 weeks, the symptoms were obviously improved, and after 3 months, the symptoms disappeared. After 5 years of follow-up, there was no recurrence and the body was healthy.

Claims (2)

1. Chinese medicine composition for the treatment of chronic atrophic gastritis, according to monarch, minister, help, make and carry out the compatibility component, it is characterized in that: Rhizoma Pinelliae Preparatum is a monarch drug; Rhizoma Coptidis, Rhizoma Zingiberis, Radix Ginseng are ministerial drug; Radix Scutellariae, Cortex Magnoliae Officinalis, Olibanum are adjuvant drug; Radix Glycyrrhizae Preparata is a messenger drug; And the constituent of Chinese medicine composition and percentage by weight are: Rhizoma Pinelliae Preparatum 3.5%-4%, Rhizoma Coptidis 18%-19%, Rhizoma Zingiberis 18%-19%, Radix Ginseng 9%-9.5%, Radix Scutellariae 18%-19%, Cortex Magnoliae Officinalis 9%-9.5%, Olibanum 3.5%-4%, Radix Glycyrrhizae Preparata 18%-19%.
2. a kind of Chinese medicine composition for the treatment of chronic atrophic gastritis according to claim 1, the constituent and the percentage by weight thereof that it is characterized in that this Chinese medicine composition are: Rhizoma Pinelliae Preparatum 3.7%, Rhizoma Coptidis 18.5%, Rhizoma Zingiberis 18.5%, Radix Ginseng 9.3%, Radix Scutellariae 18.5%, Cortex Magnoliae Officinalis 9.3%, Olibanum 3.7%, Radix Glycyrrhizae Preparata 18.5%.
CNB200510107415XA 2005-09-30 2005-09-30 A traditional Chinese medicine composition for treating chronic atrophic gastritis Expired - Fee Related CN100361705C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB200510107415XA CN100361705C (en) 2005-09-30 2005-09-30 A traditional Chinese medicine composition for treating chronic atrophic gastritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB200510107415XA CN100361705C (en) 2005-09-30 2005-09-30 A traditional Chinese medicine composition for treating chronic atrophic gastritis

Publications (2)

Publication Number Publication Date
CN1745844A CN1745844A (en) 2006-03-15
CN100361705C true CN100361705C (en) 2008-01-16

Family

ID=36165662

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB200510107415XA Expired - Fee Related CN100361705C (en) 2005-09-30 2005-09-30 A traditional Chinese medicine composition for treating chronic atrophic gastritis

Country Status (1)

Country Link
CN (1) CN100361705C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9193756B2 (en) 2008-02-19 2015-11-24 National University Corporation Asahikawa Medical College Adrenomedullin production enhancer

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108619480A (en) * 2018-08-10 2018-10-09 重庆市渝北区中医院 A kind of Chinese medicine composition that treating atrophic gastritis and its application
CN116942785B (en) * 2023-08-29 2024-09-10 北京中医药大学 Traditional Chinese medicine preparation for treating chronic atrophic gastritis and precancerous lesions of gastric cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1531961A (en) * 2003-03-18 2004-09-29 李政育 Traditional Chinese medicine for treating paraplegia

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1531961A (en) * 2003-03-18 2004-09-29 李政育 Traditional Chinese medicine for treating paraplegia

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
改良半夏泻心汤治疗慢性萎缩性胃炎实验研究. 金东明,吴巍,孙树权等.长春中医学院学报,第17卷第3期. 2001 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9193756B2 (en) 2008-02-19 2015-11-24 National University Corporation Asahikawa Medical College Adrenomedullin production enhancer

Also Published As

Publication number Publication date
CN1745844A (en) 2006-03-15

Similar Documents

Publication Publication Date Title
CN104491415A (en) Medicine for treating chronic obstructive pulmonary disease during stable period and preparation method of medicine
WO2024099339A1 (en) Traditional chinese medicine composition and use thereof
CN101745044A (en) Chinese material medica preparation for treating nasosinusitis
CN101518640A (en) Chinese traditional medicine prescription for treating tumor
CN118021898B (en) Traditional Chinese medicine composition for treating phlegm-stasis collateral obstruction type chronic atrophic gastritis with precancerous lesions
CN102988851B (en) Chinese medicine composition for treating hemoptysis and preparation method of Chinese medicine composition
CN100361705C (en) A traditional Chinese medicine composition for treating chronic atrophic gastritis
CN115040577B (en) Traditional Chinese medicine composition for treating atrophic gastritis with intestinal metaplasia and atypical hyperplasia and preparation method thereof
CN105497811A (en) Traditional Chinese medicine composition for treating liver cirrhosis and preparation technology thereof
CN102698189B (en) Chinese medicinal composition and preparation with function of treating helicobacter pylori in stomach and preparation method thereof
CN106913626B (en) A kind of pharmaceutical composition for treating enterogastritis and preparation method thereof, preparation and application
CN101327293B (en) Capsule for treating peptic ulcer and preparation method thereof
CN105267818B (en) A kind of Chinese medicine composition and preparation method thereof for treating epigastric pain
CN100409870C (en) Chinese traditional medicinal composition for treating psoriasis
CN114832079A (en) Traditional Chinese medicine composition for treating functional abdominal distension and preparation method thereof
CN113908250A (en) Traditional Chinese medicine composition for treating chronic gastritis and preparation method and application thereof
CN1144595C (en) Anticancer capsule
CN104491816A (en) Application of a kind of traditional Chinese medicine composition in the preparation of medicine for treating chronic gastroenteritis
CN117045732B (en) Traditional Chinese medicine composition for treating lipoma and preparation method and application thereof
CN118078942B (en) Composition for treating obstructive sleep apnea-hypopnea syndrome, granule preparation and preparation method thereof
CN114732882B (en) Traditional Chinese medicine composition and preparation method and application thereof
CN115845009B (en) Umbilical moxibustion medicinal powder for treating spleen deficiency and diarrhea and its application
CN103182037A (en) Traditional Chinese medicine for treating rhinitis
CN108619371A (en) A kind of Traditional Chinese medicine compound composition and preparation method thereof with treatment kidney trouble
CN102552866A (en) Medicament for treating refractory and recurrent oral ulcer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Assignee: Changchun Puhua Pharmaceutical Co., Ltd.

Assignor: Changchun Institue of Applied Chemistry, Chinese Academy of Sciences

Contract record no.: 2010220000048

Denomination of invention: Chinese medicine composite for treating chronic atrophic gastritis and preparation method thereof

Granted publication date: 20080116

License type: Exclusive License

Open date: 20060315

Record date: 20101116

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080116

Termination date: 20190930